Shanghai Fosun Pharmaceutical Group Co Ltd
SWB:08HH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shanghai Fosun Pharmaceutical Group Co Ltd
SWB:08HH
|
CN |
|
M
|
Minera Alamos Inc
XMUN:PYCP
|
CA |
|
Gruma SAB de CV
F:3G3B
|
MX |
|
T
|
Toyobo Co Ltd
DUS:TO7
|
JP |
|
M
|
Mednow Inc
OTC:MDNWF
|
CA |
|
D
|
Dongfeng Motor Group Co Ltd
XMUN:D4D
|
CN |
|
O
|
Overactive Media Corp
OTC:OAMCF
|
CA |
|
E
|
Element Nutritional Sciences Inc
F:93X
|
CA |
|
Ayurcann Holdings Corp
OTC:AYURF
|
CA |
|
D
|
Daekyo Co Ltd
KRX:019685
|
KR |
|
N
|
Nifco Inc
OTC:NIFCY
|
JP |
Bankruptcy Probability
Shanghai Fosun Pharmaceutical Group Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Shanghai Fosun Pharmaceutical Group Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
|
61B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
650.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
378.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
187.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
290.6B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Shanghai Fosun Pharmaceutical Group Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Shanghai Fosun Pharmaceutical Group Co Ltd has total debt of 32.3B CNY. This includes both short-term (16.4B CNY) and long-term (16B CNY) debt.
You can find a full breakdown on its Balance Sheet.
